Cargando…
Identification of Immune-Related Candidate Biomarkers in Plasma of Patients with Sporadic Vestibular Schwannoma: Candidate Plasma Biomarkers in Vestibular Schwannoma
Vestibular schwannoma (VS) is intracranial tumor arising from neoplastic Schwann cells, causing hearing loss in about 95% of patients. The traditional belief that hearing deficit is caused by physical expansion of the VS, compressing the auditory nerve, does not explain the common clinical finding t...
Autores principales: | Vasilijic, Sasa, Atai, Nadia A., Hyakusoku, Hiroshi, Worthington, Steven, Ren, Yin, Sagers, Jessica E., Sahin, Mehmet I, Fujita, Takeshi, Landegger, Lukas D., Lewis, Richard, Welling, D. Bradley, Stankovic, Konstantina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900840/ https://www.ncbi.nlm.nih.gov/pubmed/36747696 http://dx.doi.org/10.1101/2023.01.24.525436 |
Ejemplares similares
-
Identification of immune-related candidate biomarkers in plasma of patients with sporadic vestibular schwannoma
por: Vasilijic, Sasa, et al.
Publicado: (2023) -
MMP-14 (MT1-MMP) Is a Biomarker of Surgical Outcome and a Potential Mediator of Hearing Loss in Patients With Vestibular Schwannomas
por: Ren, Yin, et al.
Publicado: (2020) -
Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma
por: Sagers, Jessica E., et al.
Publicado: (2018) -
Publisher Correction: Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma
por: Sagers, Jessica E., et al.
Publicado: (2018) -
New developments in neurofibromatosis type 2 and vestibular schwannoma
por: Ren, Yin, et al.
Publicado: (2020)